Researchers at Baylor College of Medicine and Washington University School of Medicine, St. Louis have identified clinical and genetic predictors of multiple recurrent meningiomas (MRMs), the most aggressive form of this common brain tumor. Published in Science Advances, the study opens new opportunities for future development of potential biomarkers and therapeutic agents for these challenging tumors.
Medical Xpress – latest medical and health news stories
